JK
John Kenneth Stipancich
About John Kenneth Stipancich
Data last updated:
John Kenneth Stipancich is a Director at Deltek Replicon Software (India) Private Limited (since 2023), Director at Vertafore India Private Limited (since 2022) and Director at Clinisys (India) Private Limited (since 2017), and holds 4 more current directorships. The companies operate in Information Technology, Business Outsourcing and Business Services. The 7 current companies with reported revenue have a combined latest revenue of ₹481 Cr; the largest is Deltek Replicon Software (India) Private Limited at ₹172 Cr (FY 2025). Earlier, John Kenneth Stipancich was a Director at Ri Marketing India Private Limited (2022–2024) and Director at Lenox India Private Limited (2009–2015) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Aug 2023 | 2006 | ₹172 Cr (FY 2025) | Active | |
| Director | 01 Feb 2022 | 1998 | ₹150 Cr (FY 2025) | Active | |
| Director | 26 Oct 2017 | 2007 | ₹116 Cr (FY 2025) | Active | |
| Director | 19 Aug 2020 | 2020 | ₹20.15 Cr (FY 2025) | Active | |
| Director | 18 Feb 2022 | 2018 | ₹9.85 Cr (FY 2025) | Active | |
| Director | 15 Mar 2022 | 2022 | ₹6.50 Cr (FY 2023) | Active | |
| Additional Director | 18 Oct 2024 | 2012 | ₹5.73 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Dec 2022 | 2010 | ₹13.27 Cr (FY 2025) | Active | |
| Director | 31 Dec 2009 | 1997 | ₹34.85 Cr (FY 2018) | Amalgamated | |
| Director | 31 Dec 2009 | 1998 | ₹270 Cr (FY 2025) | Active | |
| Director | 15 Dec 2016 | 1999 | ₹5.87 Cr (FY 2016) | Dissolved Under Section 59(8) |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of John Kenneth Stipancich
Directorship timeline
Open interactive timeline →Shareholding and investment profile for John Kenneth Stipancich
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about John Kenneth Stipancich
John Kenneth Stipancich currently holds 7 directorships: Deltek Replicon Software (India) Private Limited (Director, since 21 Aug 2023, revenue ₹172 Cr (FY 2025)); Vertafore India Private Limited (Director, since 01 Feb 2022, revenue ₹150 Cr (FY 2025)); Clinisys (India) Private Limited (Director, since 26 Oct 2017, revenue ₹116 Cr (FY 2025)); Datsolutions Private Limited (Director, since 19 Aug 2020, revenue ₹20.15 Cr (FY 2025)); American Legalnet India Private Limited (Director, since 18 Feb 2022, revenue ₹9.85 Cr (FY 2025)); and 2 more.
John Kenneth Stipancich was first appointed on 31 Dec 2009 as Director at Lenox India Private Limited. The most recent appointment on record is 18 Oct 2024 at Transact Campus India Private Limited.
The 7 current companies of John Kenneth Stipancich that report revenue have a combined latest revenue of ₹481 Cr: Deltek Replicon Software (India) Private Limited ₹172 Cr (FY 2025); Vertafore India Private Limited ₹150 Cr (FY 2025); Clinisys (India) Private Limited ₹116 Cr (FY 2025); Datsolutions Private Limited ₹20.15 Cr (FY 2025); American Legalnet India Private Limited ₹9.85 Cr (FY 2025); and 2 more.
John Kenneth Stipancich held 4 earlier board appointments: Ri Marketing India Private Limited (Director, 15 Dec 2022 to 05 Jul 2024); Lenox India Private Limited (Director, 31 Dec 2009 to 25 Sep 2015); Reynolds Pens India Private Limited (Director, 31 Dec 2009 to 12 Nov 2014); Foodlink It India Private Limited (Director, from 15 Dec 2016).
The current boards of John Kenneth Stipancich's companies include Girish Chandran Nair (Deltek Replicon Software (India) Private Limited), Shoba Duraikkannan (Deltek Replicon Software (India) Private Limited), Tracy Lyn Schampers (Deltek Replicon Software (India) Private Limited), Robert William Fincutter (Vertafore India Private Limited), Sathbir Kaur (Vertafore India Private Limited), Andrew E Branski (Clinisys (India) Private Limited), among others.